Nevirapine hemihydrate is a non-nucleoside reverse transcriptase inhibitor (NNRTI) medication utilized in combination antiretroviral therapy to treat and prevent HIV-1 infection in patients aged six years… Read more
Nevirapine hemihydrate is a non-nucleoside reverse transcriptase inhibitor (NNRTI) medication utilized in combination antiretroviral therapy to treat and prevent HIV-1 infection in patients aged six years and older. This antiretroviral agent functions by binding directly to the HIV-1 reverse transcriptase enzyme, effectively inhibiting viral replication. The category below contains high-quality reference standards essential for comprehensive pharmaceutical analysis, including Nevirapine hemihydrate active pharmaceutical ingredients (API), pharmacopeial and non-pharmacopeial impurities, degradation products, and metabolites. These compounds are critical for researchers and analytical chemists conducting impurity profiling, method validation, and rigorous quality control testing. Furthermore, the inclusion of stable isotope labelled compounds facilitates accurate quantification and the development of sensitive assays for pharmacokinetic studies. By providing access to these specialized materials, laboratories can ensure the precision and reliability of analytical methods throughout the drug development and manufacturing lifecycle of this essential HIV medication.